Treatment-free interval as an additional measure of efficacy in a large UK dataset of transplant ineligible myeloma patients

Treatment of transplant-ineligible (TNE) newly diagnosed multiple myeloma (NDMM) requires a balance between disease control and maintaining quality of life (QoL). Patients value treatment-free remission periods in this incurable condition, as they are associated with better QoL. We set out to study...

Descripción completa

Detalles Bibliográficos
Autores principales: Djebbari, Faouzi, Sharpley, Faye A., McLain-Smith, Susan, Vallance, Grant, Eyre, Toby A., Kothari, Jaimal, Moore, Sally, Ramasamy, Karthik
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7034914/
https://www.ncbi.nlm.nih.gov/pubmed/32084254
http://dx.doi.org/10.1371/journal.pone.0229469

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7034914/
https://www.ncbi.nlm.nih.gov/pubmed/32084254
http://dx.doi.org/10.1371/journal.pone.0229469

Ejemplares similares